Characteristics of enrolled patients at baseline according to outcome status^*.

<p>*Results may not add due to missing values.</p><p>**Only 7 patients were known to be HIV-positive because HIV testing is rarely performed.</p

Crude and adjusted marginal models assessing weight change over time according to outcome status.

<p>*Adjusted by age, gender, type of tuberculosis, scheme of treatment, HIV status, and sputum variation during follow-up.</p

Weight change over time during treatment follow-up according to outcome status (adjusted model*).

<p>* Predicted lines were adjusted for age, gender, type of tuberculosis, scheme of treatment, HIV status, and sputum variation during follow-up.</p

Weight change over time during follow-up according to outcome status.

<p>Weight change over time during follow-up according to outcome status.</p

List of primers used for the B&S MG-LAMP.

(DOCX)</p

Cost and TAT of B&S MG-LAMP assay and expert microscopy for 8 samples (One strip of tubes).

Cost and TAT of B&S MG-LAMP assay and expert microscopy for 8 samples (One strip of tubes).</p

Mixed infections results.

Comparison of results of mixed infections (Pf/Pv) performed by each methodology. (DOCX)</p

Comparison of the B&S MG-LAMP and field microscopy with expert microscopy.

(DOCX)</p

Individual test results for passive surveillance component.

(XLSX)</p

Results of positive from the active surveillance study.

The remaining 493 samples were negative.</p